F

FibroBiologics
D

FBLG

0.40320
USD
-0.03
(-7.54%)
قبل الجلسة
حجم التداول
100
الربح لكل سهم
-0
العائد الربحي
-
P/E
-1
حجم السوق
26,913,880
المقالات

العنوان: FibroBiologics

القطاع: Healthcare
الصناعة: Biotechnology
FibroBiologics Inc a clinical-stage biotechnology company focused on developing and commercializing fibroblast-based therapies for patients suffering from chronic diseases with unmet medical needs, including wound healing, multiple sclerosis, or MS, degenerative disc disease, psoriasis, certain cancers, and potential human longevity applications including thymic involution reversal using a thymic organoid. Its product candidates are CYWC628, CYPS317, CYMS101 and CybroCell.